Close
  Indian J Med Microbiol
 

Figure 3: Variation in doses for fixed-geometry and flexible-geometry applicators based plans of individualized patients for (a) high-risk clinical target volume D90 (%) and (b) high-risk clinical target volume D100 (%)

Figure 3: Variation in doses for fixed-geometry and flexible-geometry applicators based plans of individualized patients for (a) high-risk clinical target volume D<sub>90</sub> (%) and (b) high-risk clinical target volume D<sub>100</sub> (%)